The cognitive cost of reducing relapse to cocaine-seeking with mGlu5 allosteric modulators.

These results emphasize the relevance of evaluating cognitive function within the context of investigating pharmacotherapies to treat CUD. Further research is needed to determine how two mechanistically different pharmacological compounds can exert the same behavioral effects to reduce cocaine-seeking.